Search results with tag "Fondaparinux"
Corretto utilizzo di Eparine e Fondaparinux …
www.aslcn2.itCorretto utilizzo di Eparine e Fondaparinux nell’ambito di profilassi e trattamento dei Tromboembolismi 1° stesura - 1° revisione luglio 2010 - giugno 2013
CONVERSION (“SWITCHING”) AMONG PARENTERAL …
depts.washington.eduStop fondaparinux and give first dose of LMWH at the time the next dose of fondaparinux would have been given . UWMedicine Anticoagulation Services June 2015 : Author: Wittkowsky, Ann K …
ORIENTAÇÕES SOBRE O TRATAMENTO FARMACOLÓGICO …
www.gov.brFondaparinux Dose padrão 2,5 mg, SC, 1x/dia Insuficiência renal (ClCr 20 a 30 ml/min) 2,5 mg, SC, a cada 48h Insuficiência renal (ClCr < 20 ml/min) Não utilizar ClCr: Clearance da creatinina. IMC (índice de massa corpórea) = peso em kg / (altura em cm)2 3. ANTIMICROBIANOS 3.1. Recomendamos não utilizar antimicrobianos em pacientes com
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euTreatment should be regularly evaluated in the individual patient weighing the risk for ischaemic ... In patients with an acute thrombotic event or vascular procedure and a need for dual antiplatelet ... heparin derivatives (fondaparinux, etc.), oral anticoagulants (warfarin, dabigatran etexilate, apixaban, etc.) except under specific ...
RBP - PREVENTION ET TRAITEMENT DE LA MALADIE …
ansm.sante.frSous fondaparinux, il est recommandé de ne pas réaliser cette surveillance (Grade B). L’utilisation des thrombolytiques n’est pas recommandée en première intention à la phase aiguë (Grade B). Ils peuvent être utilisés par voie veineuse en cas de syndrome obstructif sévère ou
Therapeutic Hypothermia Protocol for Cardiac Arrest
www.med.upenn.eduo Arixtra(fondaparinux) 2.5mg SQ daily Phase 2/ Maintenance: This phase begins when the patient reaches 32-34 C. Document time patient reaches target temperature in EMR. Monitor and document Vital Signs at least every 1 hour and more often as patient hemodynamic status dictates. Patient temperature, Arctic Sun water temperature and
The Renal Drug Handbook - SGUL
www.gicu.sgul.ac.ukFondaparinux sodium 329 Formoterol fumarate (eformoterol) 330 Fosamprenavir 331 Foscarnet sodium 332 Fosinopril sodium 333 Fosphenytoin sodium 334 Frovatriptan 336 Fulvestrant 337 Furosemide (frusemide) 338 Gabapentin 340 Galantamine 341 Ganciclovir 342 Gemcitabine 343 Gemfibrozil 344 Gentamicin 345 Glibenclamide 346 Gliclazide 347 Glimepiride 348
Contract : 5753 Vendor : Quest Diagnostics Description ...
www.unlv.eduprofile 283 immune compet 283 $198.35 sra assay fondaparinux 16285 $91.00 c3, c4, complement ch50 284 $65.49 platelet ab scr indirect 16288 $80.50 allergen grasses profile 300 $35.00 quant hiv-1 rt pcr (nih) 16290 $103.25 allergen weeds profile 301 $28.00 gtt gestational 4 spec 16292 $14.98
Trigger Point Injections What To Expect - Kaiser …
mydoctor.kaiserpermanente.org(Lovenox), Fondaparinux (Arixtra), or heparin. These medications need to be discontinued before the pro-cedure. Discuss this with your doctor or cardiologist in order to weigh the risks and benefits of stopping these medicines. It is OK to take Tylenol for other pain like arthri-tis, pain from previous operations, abdominal pain, and headaches.
Stroke Performance Measures - Centers for Disease Control ...
www.cdc.govfondaparinux is recommended if there are no contraindications. Aspirin alone is not recommended as an agent to prevent VTE. Clinical Practice Guidelines Supporting Measure: Ralph L. Sacco, Robert Adams, Greg Albers, Mark J. Alberts, Oscar Benavente, ; Karen
ALLEGATO I RIASSUNTO DELLE CARATTERISTICHE …
www.ema.europa.euTrattamento concomitante con altri anticoagulanti, come le eparine non frazionate, le eparine a basso peso molecolare (enoxaparina, dalteparina, ecc.), i derivati d ell’eparina (fondaparinux, ecc.
Arixtra, INN: Fondaparinux sodium
www.ema.europa.eu3/45 EMEA 2004 Product Specification The product specification is essentially the same as the active substance specification, with additional
Protocollo Aziendale - Alba e Bra
www.aslcn2.itCorretto utilizzo di Eparine e Fondaparinux nell’ambito di profilassi e trattamento dei Tromboembolismi Protocollo Aziendale 1° stesura luglio 2010
Fondaparinux for the treatment of Acute Coronary …
www.dbth.nhs.ukACUTE CORONARY SYNDROMES (ACS) Fondaparinux is synthetic pentasaccharide that inhibits activated factor X. It is the antithrombotic of choice for the treatment of ACS within the Trust. Unstable angina (UA) and Non ST Elevation MI (NSTEMI) Treatment of UA or NSTEMI in patients for whom urgent management (<120mins) with PCI is not indicated